On April 27, 2023, it was reported that Citigroup analyst Jason Cassorla has increased the price target of Universal Health Services (UHS) from $150 to $165 while maintaining a Buy rating. UHS is a leading healthcare service provider with a market cap of $10.12B. The company recently announced its financial results for the first quarter of 2023 on February 27, 2023. The results revealed earnings of $2.34 per share, exceeding the Zacks Consensus Estimate of $2.15 per share.
As of April 25, 2023, UHS’s stock price closed at $142.22 with a volume of 26,200. The stock has witnessed a 2% increase this year. Citigroup has further revised its price target on UHS to $188 from $170, reiterating a Buy rating. Similarly, Stephens has also adjusted its price target on UHS to $145 from $140, maintaining a Buy rating.
In conclusion, UHS has received a Buy rating from Citigroup analyst Jason Cassorla with an increased price target of $165. The company has reported impressive earnings in its first-quarter financial results for 2023. The stock has seen a modest increase of 2% this year and has received positive price target revisions from both Citigroup and Stephens.
Universal Health Services (UHS) Gains 1.72% on Strong Market Capitalization and Steady Revenue Growth
On April 27, 2023, Universal Health Services (UHS) opened at $143.71 and closed at $145.24, representing a gain of $2.45 or 1.72% for the day. UHS had a volume of 285,103 shares traded, and its market capitalization is $9.8 billion with a P/E ratio of 15.8. The company operates hospitals, behavioral health centers, and outpatient facilities across the United States, Puerto Rico, and the United Kingdom, and has been growing steadily with revenue growth of 5.99% last year and an expected earnings growth of 9.01% over the next five years. UHS is expected to report earnings per share of $2.38 this quarter, with the next reporting date set for July 24, 2023.
Universal Health Services Inc (UHS) Stock Analysis: 12-Month Price Forecasts and Target Price
On April 27, 2023, Universal Health Services Inc (UHS) stock performed well, with a median target price of $147.50, representing a +2.20% increase from the last price of $144.32. This target price was based on the 12-month price forecasts of 18 analysts, with a high estimate of $167.00 and a low estimate of $124.00.
Source: beststocks.com
